Mondelez International, Inc.

SNSE:MDLZ Stock Report

Market Cap: US$87.0b

Mondelez International Valuation

Is MDLZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MDLZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MDLZ ($57.88) is trading below our estimate of fair value ($117.27)

Significantly Below Fair Value: MDLZ is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MDLZ?

Key metric: As MDLZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MDLZ. This is calculated by dividing MDLZ's market cap by their current earnings.
What is MDLZ's PE Ratio?
PE Ratio22.8x
EarningsUS$3.82b
Market CapUS$87.00b

Price to Earnings Ratio vs Peers

How does MDLZ's PE Ratio compare to its peers?

The above table shows the PE ratio for MDLZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.8x
AQUACHILE Empresas AquaChile
5.5xn/aCL$985.0b
CAROZZI Carozzi
5.9xn/aCL$557.7b
WATTS Watt's
9.7xn/aCL$211.5b
SALMOCAM Salmones Camanchaca
50.1x65.6%CL$172.5b
MDLZ Mondelez International
22.8x10.6%US$87.0b

Price-To-Earnings vs Peers: MDLZ is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the peer average (17.8x).


Price to Earnings Ratio vs Industry

How does MDLZ's PE Ratio compare vs other companies in the South American Food Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
MDLZ 22.8xIndustry Avg. 9.8xNo. of Companies14PE0816243240+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MDLZ is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the South American Food industry average (9.8x).


Price to Earnings Ratio vs Fair Ratio

What is MDLZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MDLZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.8x
Fair PE Ratio19.6x

Price-To-Earnings vs Fair Ratio: MDLZ is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the estimated Fair Price-To-Earnings Ratio (19.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MDLZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$57.88
US$80.36
+38.8%
4.6%US$92.00US$75.00n/a25
Nov ’25US$57.88
US$80.73
+39.5%
4.4%US$92.00US$75.00n/a25
Oct ’25US$57.88
US$80.01
+38.2%
4.5%US$88.00US$75.00n/a24
Sep ’25US$57.88
US$78.42
+35.5%
4.8%US$88.00US$73.00n/a24
Aug ’25US$57.88
US$78.31
+35.3%
5.5%US$88.00US$70.00n/a23
Jul ’25US$57.88
US$80.22
+38.6%
5.0%US$90.00US$73.00n/a23
Jun ’25US$57.88
US$81.30
+40.5%
4.2%US$90.00US$75.00n/a24
May ’25US$57.88
US$81.52
+40.8%
4.7%US$90.00US$73.00n/a24
Apr ’25US$57.88
US$83.10
+43.6%
4.1%US$89.00US$73.00n/a25
Mar ’25US$57.88
US$83.22
+43.8%
4.1%US$89.00US$73.00n/a25
Feb ’25US$57.88
US$82.69
+42.9%
4.5%US$89.00US$73.00n/a25
Jan ’25US$57.88
US$80.10
+38.4%
5.5%US$89.00US$69.00n/a24
Dec ’24US$57.88
US$79.19
+36.8%
6.0%US$89.00US$69.00n/a23
Nov ’24US$57.88
US$78.69
+35.9%
7.7%US$89.00US$65.00US$57.8822
Oct ’24US$57.88
US$82.18
+42.0%
5.4%US$89.00US$70.00US$57.8823
Sep ’24US$57.88
US$82.62
+42.8%
5.3%US$89.00US$70.00US$57.8821
Aug ’24US$57.88
US$82.71
+42.9%
5.3%US$89.00US$70.00US$57.8821
Jul ’24US$57.88
US$80.80
+39.6%
5.2%US$86.00US$70.00US$57.8821
Jun ’24US$57.88
US$81.00
+39.9%
5.3%US$86.00US$70.00US$57.8821
May ’24US$57.88
US$79.67
+37.7%
6.4%US$86.00US$69.00US$57.8823
Apr ’24US$57.88
US$74.46
+28.6%
4.5%US$80.00US$69.00US$57.8823
Mar ’24US$57.88
US$74.31
+28.4%
4.8%US$80.00US$66.00US$57.8824
Feb ’24US$57.88
US$74.04
+27.9%
5.1%US$80.00US$66.00US$57.8824
Jan ’24US$57.88
US$72.13
+24.6%
4.4%US$77.00US$66.00US$57.8824
Dec ’23US$57.88
US$71.02
+22.7%
3.7%US$76.00US$66.00US$57.8823
Nov ’23US$57.88
US$69.45
+20.0%
5.1%US$75.00US$63.00US$57.8822

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies